Trinity Biotech (Nasdaq:TRIB) announced today that it entered into a strategic collaboration with drug delivery tech developer Latch Medical. Latch Medical develops Pharma Latch, an intradermal drug delivery platform. The hollow, microneedle-based intradermal drug delivery technology is designed to enable precise, reliable and repeatable delivery of injectable therapies into the skin. The company developed it […]
Drug-Device Combinations
MiniMed says Flex insulin pump is now available through Medicare
MiniMed (Nasdaq:MMED) announced today that Medicare and Medicare Advantage beneficiaries now have access to its Flex insulin pump. Beneficiaries can now access the MiniMed Flex and its latest sensor portfolio, which currently includes the Simplera Sync sensor, a disposable, all-in-one sensor with easy two-step insertion. The company plans to roll it out with the Instinct sensor, made by […]
Inside the first-of-its-kind Enable Injections enFuse drug delivery wearable
When Sanofi won FDA approval in July 2026 for the first anticancer treatment administered with an on-body injector (OBI), the Enable Injections enFuse platform made it possible. The enFuse OBI secured its initial combination product FDA approval in 2023 for adults with paroxysmal nocturnal hemoglobinuria, a rare blood disorder. That milestone made enFuse the “first purely mechanical, large-volume, on-body […]
Baxter warns on intravascular administration sets
The FDA issued an early alert after Baxter (NYSE:BAX) recommended the removal of certain Duo-Vent intravascular administration sets. Baxter sent all affected customers a letter on June 30, telling them to immediately identify, quarantine and return affected lots. The communication affects lots DR26C27062, DR26D14031 and DR26E13055 of the Duo-Vent solution set and male luer lock adapter. Duo-Vent […]
Medtrum to bring 300U tubeless insulin patch pump to Germany
Medtrum announced today that it made further progress toward bringing its 300-unit tubeless insulin patch pump to the German market. The company said it delivered a presentation at DDG 2026 in Berlin and was included in Germany’s statutory health insurance medical aids directory for reimbursement purposes. An upcoming German launch expands the company’s presence in […]
Modular Medical inks IMO Health collab for insulin pump EHR integration
Modular Medical (Nasdaq:MODD) announced that it entered into a new pilot collaboration with IMO Health. IMO Health provides healthcare AI solutions designed to transform healthcare data into trusted clinical context. Through this pilot, San Diego-based Modular Medical aims to develop a deployable terminology-powered phenotypic algorithm designed to identify diabetes patients who may benefit from insulin […]
Abbott to launch Libre Duo dual sensor internationally in the fall, expects future reimbursement catalysts
Abbott (NYSE:ABT) plans to launch its Libre Duo dual glucose-ketone sensor internationally in the fall, company leadership said today. CEO and Chair Robert B. Ford said on the company’s second-quarter earnings call that Abbott expects the launch in a few months, following CE mark approval for the multi-analyte sensor in May. Branded as Libre Duo […]
Insulet, Calm partner on emotional well-being resources for diabetes
Insulet (Nasdaq:PODD) announced today that it has partnered with Calm, a leading consumer mental health company. The companies say they are coming together to provide emotional well-being resources for people living with diabetes, their caregivers, and healthcare professionals. Acton, Massachusetts-based Insulet said the collaboration marks Calm’s first integrated content partnership and collection with a medtech […]
ViCentra names new CFO, adds board member
ViCentra announced today that it appointed Ian Wells as its new CFO and added Thomas A. West to its board of directors. Wells’ appointment went into effect on June 19, 2026, while West became an independent director on July 1, 2026. The Utrecht, the Netherlands-based automated insulin delivery system developer said the appointments lay the […]
Dexcom picks up Health Canada nod for G7 15 Day
Dexcom (Nasdaq:DXCM) announced today that Health Canada authorized its G7 15 Day continuous glucose monitor (CGM) system. Health Canada approval covers people 18 years and older living with diabetes. It brings the G7 15 Day, its longest-lasting wearable sensor, to Canada, with the system already possessing FDA clearance. G7 15 Day delivers several features of […]
